Pretreatment Hepatitis C Virus NS5A/NS5B resistance-associated substitutions in genotype 1 uruguayan infected patients

Hepatitis C Virus (HCV) infection treatment has dramatically changed with the advent of direct-acting antiviral agents (DAAs). However, the efficacy of DAAs can be attenuated by the presence of resistance-associated substitutions (RASs) before and after treatment. Indeed, RASs detected in DAA treatm...

ver descrição completa

Detalhes bibliográficos

Autor principal:	Aldunate Caramori, Fabián (author)
Outros Autores:	Echeverría Chagas, Natalia (author), Chiodi, Daniela (author), López, Pablo (author), Sánchez Cicerón, Adriana (author), Fajardo Rossi, Álvaro (author), Sóñora, Martín (author), Cristina, Juan (author), Hernández, Nelia (author), Moreno Karlen, María del Pilar (author)
Formato:	article
Idioma:	inglês
Publicado em:	2018
Assuntos:	Hepacivirus Hepatitis C Antivirals DAAs
Acesso em linha:	https://hdl.handle.net/20.500.12008/22071
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!